Skip to main content Accessibility help
×
Home

Multichannel auditory brainstem implant: US clinical trial results

  • K. Ebinger (a1), S. Otto (a1), J. Arcaroli (a2), S. Staller (a1) and P. Arndt (a1)...

Abstract

Since 1994, a US Food and Drug Administration clinical trial evaluated the multichannel auditory brainstem implant (ABI) on 92 subjects with neurofibromatosis type 2 (NF2). The trial has shown that 85 per cent of patients receive auditory sensations. A small number of patients demonstrate a clinically significant degree of open-set sentence recognition in the sound-alone condition; however, when the ABI is combined with lip-reading cues, 93 per cent of patients demonstrate improved sentence understanding at three to six months. In addition, the majority of recipients report daily use of their devices, and satisfaction with the decision to receive the ABI.

Copyright

Keywords

Multichannel auditory brainstem implant: US clinical trial results

  • K. Ebinger (a1), S. Otto (a1), J. Arcaroli (a2), S. Staller (a1) and P. Arndt (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed